Get the Stockscreener App
105.02
0.05%
0.05
After Hours:
104.99
-0.03
-0.03%
Boston Scientific Corp Stock (BSX) Latest News
Boston Scientific (NYSE:BSX) Announces Earnings Results - MarketBeat
Farapulse boosts Boston Scientific’s Q4 electrophysiology sales by 172% - Medical Device Network
Boston Scientific (NYSE:BSX) Releases Quarterly Earnings Results - MarketBeat
March 28th Options Now Available For Boston Scientific (BSX) - Nasdaq
Boston Scientific (NYSE:BSX) Hits New 1-Year High Following Better-Than-Expected Earnings - MarketBeat
RBC Capital raises Boston Scientific price target to $116 - Investing.com India
Boston Scientific Corporation (NYSE:BSX) Q4 2024 Earnings Call Transcript - MSN
Truist lifts Boston Scientific stock target to $120, maintains Buy - Investing.com
Mizuho raises Boston Scientific target to $130, maintains Outperform - Investing.com
Canaccord raises Boston Scientific stock target to $117 - Investing.com
Boston Scientific Co. (NYSE:BSX) Shares Sold by Long Run Wealth Advisors LLC - MarketBeat
Boston Scientific sales increase 22.4% to USD 4.561 billion in Q4 2024 - Medical Buyer
Boston Scientific Corp (BSX) Q4 2024 Earnings Call Highlights: Record Revenue Growth and Strong ... - Yahoo Finance
Boston Scientific Shines with Strong Earnings Performance - TipRanks
Boston Sci’s Farapulse tops $1B in 2024, bright prospects for 2025 - BioWorld Online
Boston Scientific remains bullish despite tariffs, with sales buoyed by Minnesota tech - MSN
How Boston Sci Leaned On Its New Heart Device For A Fourth-Quarter Beat - Yahoo! Voices
New Heart Device Pumps Earnings Beat For This Stock - Investor's Business Daily
Arthur C. Butcher Sells 17,313 Shares of Boston Scientific Co. (NYSE:BSX) Stock - MarketBeat
Boston Scientific expects double-digit sales growth in 2025 following Street-beating Q4 - Mass Device
Sector Update: Health Care -February 05, 2025 at 01:33 pm EST - Marketscreener.com
Boston Scientific targets 12%-14% EPS growth for 2025 with strong FARAPULSE and WATCHMAN momentum - MSN
Boston Scientific announces results for fourth quarter and full year 2024 - BioSpace
Boston Scientific closes its year of PFA on a high note - MedTech Dive
Boston Scientific Beats Quarterly Revenue Views; 2025 Outlook Implies Deceleration - Marketscreener.com
Boston Scientific clocks over $1B in Farapulse revenue for the afib therapy's first year - Fierce Biotech
Boston Scientific Projects Rosy 2025 Profits With Device Demand Surge - Finimize
Boston Scientific : Interested in our Q4 2024 earnings -February 05, 2025 at 09:58 am EST - Marketscreener.com
Boston Scientific Corporation Provides Earnings Guidance for the First Quarter and Full Year of 2025 - Marketscreener.com
Boston Scientific (BSX) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates - Yahoo Finance
Boston Scientific sees higher-than-expected 2025 profit on strong demand - MSN
Boston Scientific Beats Its Own Fourth-Quarter Guidance On Cardiovascular Strength - Yahoo! Voices
Boston Scientific Corporation Reports Earnings Results for the Fourth Quarter Ended December 31, 2024 - Marketscreener.com
Boston Scientific Clocks 22% Jump In Q4 Sales On Strong Heart Devices, Profit And Guidance Exceeds Expectations - Benzinga
Boston Scientific Q4 2024 Earnings Preview - MSN
Boston Scientific (NYSE:BSX) Updates Q1 2025 Earnings Guidance - MarketBeat
Boston Scientific (NYSE:BSX) Releases FY 2025 Earnings Guidance - MarketBeat
Boston Scientific Co. (NYSE:BSX) Shares Acquired by Jackson Wealth Management LLC - MarketBeat
Boston Scientific (BSX) Surpasses Q4 Earnings and Revenue Estimates - Yahoo Finance Australia
Boston Scientific earnings beat by $0.04, revenue topped estimates - Investing.com
Boston Scientific Corp (BSX) Q4 2024 Earnings: Revenue Surpasses - GuruFocus.com
Boston Scientific 4Q Profit Up on Strong Cardio Device Sales - AllSides
Boston Scientific: Q4 Earnings Snapshot - The Washington Post
Boston Scientific reports above-consensus Q4 results, provides outlook - Investing.com
Boston Scientific: Q4 Earnings Snapshot -February 05, 2025 at 06:50 am EST - Marketscreener.com
Boston Scientific Corporation’s Q4 2024 Net Sales Surge by 22.4%, Exceeding Expectations - The Tokenist
Boston Scientific (NYSE:BSX) Reports Bullish Q4, Guides for Strong Sales Next Quarter - Yahoo Finance
Yousif Capital Management LLC Has $20.76 Million Stock Position in Boston Scientific Co. (NYSE:BSX) - MarketBeat
Boston Scientific: Q4 Earnings Snapshot | National Business News | voiceofalexandria.com - Voice Of Alexandria
Boston Scientific Reports Results For Q4 And FY 2024 -February 05, 2025 at 06:47 am EST - Marketscreener.com
Mather Group LLC. Has $807,000 Stock Position in Boston Scientific Co. (NYSE:BSX) - MarketBeat
Boston Scientific Q4 24 Earnings Conference Call At 8:00 AM ET - Nasdaq
Ninety One UK Ltd Sells 591,945 Shares of Boston Scientific Co. (NYSE:BSX) - MarketBeat
The Zacks Analyst Blog Highlights Boston Scientific, Hologic, BioTechne, STERIS And Align - Barchart
The Zacks Analyst Blog Highlights Boston Scientific, Hologic, BioTechne, STERIS and Align - Yahoo Finance
Golden State Equity Partners Has $971,000 Stock Holdings in Boston Scientific Co. (NYSE:BSX) - MarketBeat
Boston Scientific Co. (NYSE:BSX) Shares Sold by Beach Investment Counsel Inc. PA - MarketBeat
0.76%
1.58%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):